Clinical Trial Update: Atorvastatin in Management of Newly Diagnosed ITP [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on atorvastatin for management of newly diagnosed immune thrombocytopenia (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia
• Purpura Thrombocytopenic

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia, Purpura, Thrombocytopenic | Phase 2, Phase 3 | Status: UNKNOWN